US4287341A
(en)
*
|
1979-11-01 |
1981-09-01 |
Pfizer Inc. |
Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
|
US6723727B1
(en)
*
|
1996-12-20 |
2004-04-20 |
Hoechst Aktiengesellschaft |
Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
|
DE69842109D1
(de)
*
|
1997-08-21 |
2011-03-10 |
Shiseido Co Ltd |
Chinazolin-4-on Derivate, deren Herstellung und deren Verwendung als Haarwuchsmittel oder in äusserlich anzuwendenden Hautpflegemitteln
|
AU7734700A
(en)
*
|
1999-10-01 |
2001-05-10 |
Advanced Medicine, Inc. |
Macrocyclic quinazolinones and their use as local anesthetics
|
SI2223922T1
(sl)
*
|
2000-04-25 |
2016-04-29 |
Icos Corporation |
Inhibitorji humane fosfatidil-inositol 3-kinazne delta izoforme
|
US6667300B2
(en)
*
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
AUPR201600A0
(en)
*
|
2000-12-11 |
2001-01-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Quinazolinone derivative
|
US20030119834A1
(en)
*
|
2001-09-05 |
2003-06-26 |
Bamdad Cynthia C. |
Compositions and methods of treatment of cancer
|
EP2116248A1
(en)
|
2001-09-05 |
2009-11-11 |
Minerva Biotechnologies Corporation |
Compositions and Methods of Treatment of Cancer
|
CA2465491A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
AUPS019702A0
(en)
*
|
2002-01-29 |
2002-02-21 |
Fujisawa Pharmaceutical Co., Ltd. |
Condensed heterocyclic compounds
|
JP2005536553A
(ja)
*
|
2002-08-21 |
2005-12-02 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
AU2003291761A1
(en)
*
|
2002-11-04 |
2004-06-07 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
DE602004022819D1
(de)
*
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
US20050054614A1
(en)
*
|
2003-08-14 |
2005-03-10 |
Diacovo Thomas G. |
Methods of inhibiting leukocyte accumulation
|
WO2005016348A1
(en)
*
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
HUE030950T2
(en)
|
2004-05-13 |
2017-06-28 |
Icos Corp |
Quinazolinones as 3-kinase delta inhibitors of human phosphatidylinositol
|
CA2567883A1
(en)
*
|
2004-05-25 |
2005-12-15 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
WO2006089106A2
(en)
*
|
2005-02-17 |
2006-08-24 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
EP2233472B1
(en)
*
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
US9492449B2
(en)
|
2008-11-13 |
2016-11-15 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
CA3092449A1
(en)
|
2008-11-13 |
2010-05-20 |
Gilead Calistoga Llc |
Therapies for hematologic malignancies
|
EP2411391A1
(en)
|
2009-03-24 |
2012-02-01 |
Gilead Calistoga LLC |
Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
|
ES2548253T3
(es)
*
|
2009-04-20 |
2015-10-15 |
Gilead Calistoga Llc |
Métodos para el tratamiento de tumores sólidos
|
MX2012000817A
(es)
|
2009-07-21 |
2012-05-08 |
Gilead Calistoga Llc |
Tratamiento para desordenes del higado con inhibidores pi3k.
|
BRPI1003506B1
(pt)
|
2010-09-24 |
2019-12-03 |
Ache Int Bvi Ltd |
composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a
|
US9353067B2
(en)
|
2011-04-10 |
2016-05-31 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
PE20141792A1
(es)
|
2012-03-05 |
2014-12-07 |
Gilead Calistoga Llc |
Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona
|
ES2595240T3
(es)
|
2012-07-09 |
2016-12-28 |
Lupin Limited |
Derivados de tetrahidroquinazolinona como inhibidores de PARP
|
EP3083623A1
(en)
|
2013-12-20 |
2016-10-26 |
Gilead Calistoga LLC |
Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one
|
CA2934531C
(en)
|
2013-12-20 |
2020-02-25 |
Gilead Calistoga Llc |
Process methods for phosphatidylinositol 3-kinase inhibitors
|
CN106459005A
(zh)
|
2014-06-13 |
2017-02-22 |
吉利德科学公司 |
磷脂酰肌醇3‑激酶抑制剂
|